Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Large Is the Travel Vaccines Market Expected to Be in 2029?

Over the recent years, the market size for travel vaccines has experienced robust growth. The projection is that it will expand from $4.73 billion in 2024 to $5.09 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 7.6%. Factors such as a surge in global travel, efforts made by governments towards travel health, the spread of diseases due to globalization, rising consciousness amongst travelers, and the burgeoning travel and tourism industry have contributed to the growth witnessed in the historical context.

In the coming years, a robust growth is forecasted in the travel vaccines market. With a compound annual growth rate (CAGR) of 9.6%, it’s predicted to reach $7.36 billion in 2029. Factors driving growth during this period include an increase in business travel, emerging threats from infectious diseases, government rules and entry prerequisites, escalating demand for offbeat destinations, and partnerships among governments and pharmaceutical firms. The forecast period also expects major trends such as personalized vaccination approaches, market expansion into non-endemic areas, implementation of digital health technology, regulatory backing, streamlined approvals, and innovative advancements.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11918&type=smp

What Are The Contributors To Demand In The Travel Vaccines Market?

The travel vaccine market is anticipated to grow due to the heightened activities in travel and tourism. Travel and tourism activities encompass the transit of individuals or entities, utilizing various transportation modes such as trains, planes, boats, and other forms of transport, across different distant geographical locations. Travel vaccines serve as a safeguard for tourists and travelers, ensuring their health and safety as they engage in international travel. For instance, the Spain-based United Nations World Tourism Organization (UNWTO) reported in January 2023 that over 900 million tourists traveled internationally in 2022. This figure is double that of 2021 and 63% higher than pre-pandemic figures, reinforcing the role of travel and tourism as a key driver in the expansion of the travel vaccine market.

What Segmentation Categories Are Included In The Travel Vaccines Market Analysis?

The travel vaccines market covered in this report is segmented –

1) By Disease: Hepatitis A, Diphtheria, Pertussis, And Tetanus (DPT), Yellow Fever, Typhoid, Hepatitis B, Measles And Mumps, Rabies, Meningococcal, Other Diseases,

2) By Composition: Mono Vaccines, Combination Vaccines

3) By Booking Channel: Online Booking, In-Person Booking

4) By Application: Domestic Travel, Outbound Travel

Subsegments:

1) By Hepatitis A: Inactivated Hepatitis A Vaccine, Combination Vaccines

2) By Diphtheria, Pertussis, And Tetanus (DPT): DTP Vaccine (Diphtheria, Tetanus, Pertussis), DTaP Vaccine (Diphtheria, Tetanus, And Acellular Pertussis)

3) By Yellow Fever: Live Attenuated Yellow Fever Vaccine, Booster Dosage Vaccines

4) By Typhoid: Inactivated Typhoid Vaccine, Live Attenuated Typhoid Vaccine

5) By Hepatitis B: Recombinant Hepatitis B Vaccine, Combination Vaccines

6) By Measles And Mumps: Measles, Mumps, And Rubella (MMR) Vaccine, Measles And Rubella (MR) Vaccine

7) By Rabies: Rabies Pre-exposure Prophylaxis (PrEP), Rabies Post-exposure Prophylaxis (PEP)

8) By Meningococcal: Meningococcal Conjugate Vaccine, Meningococcal B Vaccine

9) By Other Diseases: Japanese Encephalitis, Cholera, Influenza, Other Emerging Travel Vaccines

What Upcoming Trends Are Expected To Impact The Travel Vaccines Market Globally?

The emergence of product innovation is a significant trend gaining traction in the thalassemia drug market. Major firms in this market are bringing forth innovative solutions as part of their strategy to maintain their market dominance. An example is Bluebird Bio Inc, an American biotechnology company that approved Zynteglo (betibeglogene autotemcel), a treatment for beta-thalassemia, in August 2022. Notably, Zynteglo is the first-ever cell-based, single-dose gene therapy. It is manufactured using the patient’s cells, which have been genetically modified to create functional beta-globin.

Who Are The Top-Ranked Companies In The Travel Vaccines Market Today?

Major companies operating in the travel vaccines market include Pfizer Inc., Johnson and Johnson, Merck & Co. Inc., Sanofi SA, GlaxoSmithKline plc, Biological E. Limited, Takeda Pharmaceutical Company Limited, Novavax Inc., Emergent BioSolutions UK, Serum Institute of India Pvt. Ltd., Dynavax Technologies, Bavarian Nordic A/S, Valneva SE, Panacea Biotec, Vabiotech, Inovio Pharmaceuticals, Bharat Biotech International Limited, Altimmune Inc., Bio Farma, Vaxart Inc.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/travel-vaccines-global-market-report

How Is Travel Vaccines Market Adoption Varying Across Different Regions And Sectors?

North America was the largest region in the travel vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the travel vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=11918&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model